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v“Noah, the tiller of the soil, was the first to plant a vineyard. He
drank of the wine and became drunk, and he uncovered himself
within the tent.”
—Genesis 9:20–21
oah is thus identified both as the first winemaker and the
rst to suffer embarrassment from inebriation. It has been
vident for millennia that heavy alcohol drinking could
ause social and bodily harm. The probability that moderate
ntake was less harmful or innocuous led to guidelines for a
easonable upper drinking limit. Probably the most famous
See page 1328
f these was Anstie’s Rule of a “sensible limit” of 45 ml of
thyl alcohol/day, or approximately 3 standard-sized drinks
1). In the mid-19th century, Anstie, a prominent public
ealth activist, no doubt intended his guideline for mature
en, but he recognized variation in alcohol tolerance. The
se of “sensible” rather than “safe” acknowledges that no
mount of alcohol is safe for everyone.
cientific Evidence Develops
vidence of possible benefit from moderate alcohol drink-
ng was a 20th century development. One population report
2) of an alcohol–mortality J-curve relationship preceded
thers by one-half century. In Pearl’s Baltimore study of
,248 subjects, “heavy/steady” drinkers had the highest
ortality, “abstainers” were next, and “moderate” drinkers
ad the lowest mortality. With no explanation, and in U.S.
rohibition days, his predictably cautious interpretation was
hat moderate drinking was “not harmful.” A major contri-
ution was the realization that comparing all drinkers with
bstainers masked the J-curve. Memorably, he said, “one
annot judge the role of diet by starvation or excess” (2).
More recent observational population studies (3,4) con-
istently show lower risk among lighter drinkers than
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.r
From the Oakland Medical Center and the Division of Research, Kaiser Perma-
ente Medical Care Program, Oakland, California.bstainers for atherothrombotic vascular disease, most no-
ably coronary artery disease (CAD). Points favoring a
ausal protective effect of moderate alcohol drinking include
roper time sequence, consistency in diverse healthy or
nhealthy populations, plausible biological mechanisms,
elative specificity for atherothrombotic conditions, con-
rolled trial data for surrogate end points, and weakness of
ata supporting alternative explanations (3–6). Because
AD dominates statistics for all cardiovascular (CV) dis-
ase, the alcohol relation is similar for CAD and CV.
The alcohol–CAD reports have been examined intensely
or methodological flaws (7–9). Reasonable fear of problems
onsequent to encouragement of moderate drinking con-
ributes to reluctance to accept that there is any benefit from
lcohol. Skepticism is fueled because some studies failed to
eparate ex-drinkers, including “sick quitters,” from lifelong
bstainers in the referent group, thus exaggerating apparent
enefits of lighter drinking. Although studies using lifelong
bstainers or infrequent drinkers as referents confirmed
pparent protection (4), the absence of prospective random-
zed trials with CV events as the outcome allows residual
ncertainty about CAD protection by alcohol. Conse-
uently there has been a point-counterpoint debate in the
ublished medical reports (8–11).
National Study
he analysis reported by Mukamal et al. (12) in this issue of
he Journal fits nicely into this context. This characteristically
legant presentation from a leading group in the alcohol
pidemiology field confirms a U-shaped relationship between
lcohol intake and CV mortality in a large nationwide study
opulation. As expected, most of the apparent benefit in
ight–moderate drinkers is due to lower risk of CAD death.
The analysis (12) adds to the case that the inverse
elationship of light–moderate drinking to CV mortality is
cientifically valid. One important consideration is the use
f a national sample. This aspect contributes strength to the
cientific validity of the data by countering the argument
hat data in narrower study populations might not be
eneralizable. Another important strength is directly rele-
ant to the much-debated issue of the most appropriate
eference group. In the present report (12) there is little
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March 30, 2010:1336–8 Alcohol and CV Mortalityelationship of CV death to past or infrequent drinking. If
cknowledged past drinkers are not at increased risk, it is
ess likely that misclassification of others as lifelong abstain-
rs is a factor in results.
There are published data (13) showing that increased total
ortality among ex-drinkers is due primarily to non-CV
auses. An example (Fig. 1) shows that apparent benefit of
ighter alcohol intake is essentially limited to CV deaths and
hat increased risk among ex-drinkers is primarily seen for
on-CV deaths. These specificities strengthen the likelihood
hat CAD protection by alcohol has scientific validity.
onfounding Might Act Both Ways
keptics emphasize flaws in methodology that might spu-
iously produce apparent benefit of moderate drinking,
ither via increased risk of “sick quitters” or reduced risk of
healthy drinkers.” Less attention has been given to sources
f bias that might reduce apparent benefit. One is residual
onfounding by smoking, a correlate of alcohol drinking in
ost populations. Mukamal et al. (12) nicely control for
moking, but completeness of control is always uncertain.
mprecise categorization of alcohol intake because of under-
eporting by heavy drinkers is another source of bias against
pparent benefit by moderate intake (14). By placing some
eavy drinkers in lighter categories, under-reporting distorts
lcohol-health curves. If the true relation of a harmful effect
as a threshold (i.e., no effect at light drinking but increas-
Figure 1 CV and Non-CV Deaths
Adjusted relative risk (RR) of death through 2002 by alcohol intake among
127,212 persons who supplied alcohol data at health examinations in 1978 to
1985. Red bars  RR cardiovascular (CV) death (n  8,439); blue bars  RR
non-CV death (n  13,044). Never drinkers are referent with the following
other categories: ex-drinkers; occasional (1 drink/month); and 1, 1 to 2, 3
to 5, and 6 drinks/day. Covariates are age, sex, ethnicity, body mass index,
marital status, education, and smoking. Adapted, with permission, from
Klatsky and Udaltsova (13).ng harm at heavier intake), under-reporting lowers or obliterates the threshold. With a J-curve, as in the CV
ortality association reported here (12), under-reporting
essens apparent benefit and, as for a threshold relationship,
puriously lowers the apparent threshold for harm.
he Randomized Controlled Trial (RCT) Issue
he RCT with pre-specified end points is considered the
est path to scientific truth in medical matters. Random-
zation is the best method of controlling for known and
nknown confounders. Blinding, often part of the process,
inimizes bias. The logistics of RCTs are more difficult for
tudy of lifestyle changes than for pharmacologic or proce-
ural interventions. We have no RCTs of moderate alcohol
rinking with CAD or other fatal event end points. For
thical reasons the effects of heavy drinking are not amena-
le to an RCT, but the wish for such studies of chronic
isease effects of moderate drinking is often expressed.
enerally there has been little discussion of practical con-
iderations. The hypothesized fractional benefits would
equire large numbers in a costly multicenter trial of long
uration. Even assuming such an effort, could a represen-
ative study group, after exclusions, be recruited? If an
ppropriate population was acquired, could compliance with
andomization to daily/almost daily moderate drinking or
one be maintained for years? Is blinding possible? What
lcohol dose(s) should be used? How many arms are needed
e.g., beer, liquor, white wine, red wine, alcohol-water
ixture, placebo)? These are formidable problems. We do
ave studies relevant to intermediate “surrogate” markers,
uch as high-density lipoprotein cholesterol, antithrombotic
ffects, and endothelial function. There is also promise in
natural’ experimental randomization by metabolic genetic
olymorphisms related to alcohol metabolism. Unfortu-
ately, it is likely that we will be left much-dependent upon
bservational epidemiology.
It is easy to perceive an analogy between the alcohol–
AD data and the observational data about the relation of
AD with post-menopausal hormone replacement therapy
HRT). Thus, the unexpected unfavorable outcome for
RT in the Women’s Health Initiative (15) strengthens
kepticism about the alcohol–CAD relation. There are
onsiderations that make the alcohol–CAD relationship less
ikely to be spurious than the discredited HRT–CAD
ssociation. One is the absence of adverse CAD effects of
oderate alcohol intake; this contrasts with the long-known
ro-thrombotic action of HRT. Perhaps more important is
he lower likelihood of selection bias by “knowledge” of
enefit. For decades, health-conscious women with a favor-
ble CAD lifestyle were more likely to seek HRT. However,
efore widespread media publicity about alcohol benefit in
he 1990s, few persons drank alcohol primarily to reduce
ealth risk.
Widespread current belief in potential benefit for CAD
ntroduces a new selection bias problem. More recent
bservational studies are more susceptible to this problem
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Alcohol and CV Mortality March 30, 2010:1336–8han older ones. The Mukamal et al. report (12) is probably
ree of this bias, because the alcohol data were collected in
987 and 1992. Actually, this factor could introduce bias
ither way, because both those with known high CAD risk
nd the health-conscious with low CAD risk might be more
ikely to drink for presumed benefit. Reasons for drinking or
ot drinking will need to be incorporated in future analyses.
onclusions
lthough this writer believes the case compelling, absolute
roof that persons at CAD risk obtain benefit from light–
oderate drinking will not appear soon. In the 21st century
universal sensible limit would not accommodate serious
ublic health issues such as the increased risk of female
reast cancer risk associated with even moderate drinking or
he consequences of the mixture of youthful drinking with
he motor vehicle. The risks of moderate drinking differ by
ex, age, personal history, and family history. As is often the
ase in medical practice, advice about lifestyle must be based
n something less than certainty. There is no substitute for
alanced judgment by a knowledgeable, objective health
rofessional. What is required is a synthesis of common
ense and the best available scientific facts.
eprint requests and correspondence: Dr. Arthur L. Klatsky,
aiser Permanente Medical Center, 280 West MacArthur Boule-
ard, Oakland, California 94611. E-mail: arthur.klatsky@kp.org.
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